Stock Market Today: Natco Pharma share price gained more than 7% to scale 52 week highs on Thursday during the intraday trades. The robust US sales growth led by Revlimid generics is driving earnings.

Shares of Natco Pharma on Thursday ended 2.66 per cent down at Rs 1,499.55 apiece on the BSE.

Natco Pharma Limited shared that DASH Pharmaceuticals, a company that markets, sells and distributes generic pharmaceutical products, has officially transitioned to Natco Pharma USA, the U.S ...

Natco Pharma Limited has received the final approval of its Abbreviated New Drug Application (ANDA) for lenalidomide capsules, 5mg, 10mg, 15mg, and 25mg strengths, from the US Food and Drug ...

PARSIPPANY, N.J.--(BUSINESS WIRE)--Natco Pharma Limited, a research and development (R&D)-focused pharmaceutical company based in India, today announced that DASH Pharmaceuticals, a company that ...